We've been ranked in The Times Best Law Firms 2025
Learn more
Working for Osborne Clarke
Learn more
Diversity and Inclusion in the UK
Learn more

When disruption is the norm and you’re surrounded by complexity, you need clarity. Our straight-talking experts will give you the insights and advice you need to get the right result.

We give informed opinions, not just options. We’re switched-on to the issues and confident facing the new and unknown. We can help you navigate the challenges and opportunities transforming business – and together we’ll be ready for what’s next.

Across the UK, 102 of our partners are ranked as leading individuals by Chambers UK alongside 61 practice area rankings and we are ranked in 73 practice areas by The Legal 500 with 105 individual rankings.

Connect with one of our experts

One of the things that enables us to think differently is our culture. We have a great culture and, time and time again, it’s acknowledged as being outstanding. And what’s great about that is it brings and keeps the best people working for us – plus, it attracts innovative and approachable clients, who think like us. Our culture is fundamental to our success. So we cherish and protect it, we live by our values and reward the behaviours that support them.

And our clients value this as much as our people. For us, stuffy stereotypes and fussy formality have been left in the past – where they belong. We push forward because we don’t have time for rigid hierarchies and inflated egos, but we make time for energy and ambition. And let’s not forget a big part of being the law firm of the future is reflecting the changing world around us. So we’re committed to welcoming diversity, promoting innovation and celebrating success.

Careers in the UK
Her Global Counsel
Women in Partnership


Highlighting the journeys our female partners have taken as leaders within Osborne Clarke, the work they carry out with high-profile clients, and the opportunities there are in our supportive and collaborative environment.

 

Find out more

Uk?lang=english Latest Articles

Regulatory Outlook

Sanctions and export control | UK Regulatory Outlook January 2026

OTSI publishes first Annual Review | UK Sanctions List consolidation | OTSI guidance on breach reporting best practices | HMRC compound settlement for breaches of export controls | OFSI general licences and FAQs | UK Strategic Export Control List updates | Export Control Joint Unit training and webinars 
New -
13/01/2026
Read time 6m
Regulatory Outlook

Regulated procurement | UK Regulatory Outlook January 2026

New procurement thresholds come into force on 1 January 2026 under PPN:023 | Payment compliance and contract performance notices | Government response to procurement reforms consultation | First judgments under the Procurement Act 2023 anticipated | First suppliers anticipated to be listed on Debarment List 
New -
13/01/2026
Read time 2m
Regulatory Outlook

Products | UK Regulatory Outlook January 2026

General/digital products UK: Product Regulation and Metrology Act consultations and guidance | Government response to the independent review of the Windsor framework | Call for evidence on the automated vehicles regulatory framework | EU: Toy Safety Regulation enters into force Life sciences and healthcare UK: Clinical trials regulations | UK-US pharmaceuticals deal to boost NHS access and investment | Medical devices future regime implementation | Indefinite recognition of CE marked medical devices | ABPI announces 2026 VPAG payment rate reduction to 14.5% for newer medicines | Outcome of the MHRA consultation on health institution exemptions published | EU: First four EUDAMED modules become mandatory from 28 May 2026 | Deal on comprehensive reform of EU pharmaceutical legislation | European Commission and EIB Group announce €10 billion biotech investment initiative | European Commission proposes health sector innovation package | Call on the EU to streamline the potential of biotechnology and life sciences in healthcare Sustainable products UK: PFAS in the UK and EU in 2026 | EPR in force from 1 January 2026 | Welsh government seeks exclusion from UK Internal Market Act 2020 for its DRS scheme | Consultation on extending the CE marking recognition mechanism for ESPR | Plastic packaging tax – new mass balance approach | Environmental Improvement Plan 2025 | EU Ecodesign for Sustainable Products Regulation – provisions on destruction of unsold consumer goods | First set of requirements under the EU PPWR come into effect | EU Postpones CLP Regulation Application Dates to 2028 | Guidance released prior to the ban on plastic wet wipes | Sustainable consumption actions from the European Commission's 2030 Consumer Agenda | Preparing for EU sustainable battery requirements 
New -
13/01/2026
Read time 18m

Our Experience

BMI Healthcare

Advising the management on the $2bn disposal of BMI Healthcare's private hospital operations business and related property portfolio.

Investec

Advised Investec on £100m placing for Blue Prism Group plc.

Jellyfish Group

Advising the Jellyfish Group and its investors on an innovative investment from French group Fimalac.

Just Eat

Advised Just Eat on the acquisition of City Pantry Limited, Europe’s leading B2B catering marketplace. 

Limejump

Advised the shareholders of Limejump on the sale of the company to Shell Energy.

RHYTHM AI

Advised RHYTHM AI, a UK company focused on the treatment of Atrial Fibrillation (AF), on the closure of a £2.15m seed financing round. 

The Adecco Group

Osborne Clarke advises The Adecco Group on the sale of Adecco Home Services. 

Via Novus

Advised Via Novus on £35M Cube investment into Engenie.